# A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension

Clinical trial · CRISPR Therapeutics AG

- Archive id: nct:NCT07758634
- Published: 2026-08-11
- Venue: ClinicalTrials.gov
- ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT07758634
- Source URL: https://clinicaltrials.gov/study/NCT07758634
- Provenance: clinicaltrials

## Abstract

A Study of CTX340 in Participants with Uncontrolled Hypertension.

_Abstract reproduced under ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters._

## Trial details

- status: RECRUITING
- phase: PHASE1, PHASE2
- study type: INTERVENTIONAL
- enrollment: 69
- sponsor: CRISPR Therapeutics AG
- conditions: Hypertension
- interventions: DRUG: CTX340; DRUG: Placebo
- start date: 2026-08-08
- start date type: ESTIMATED
- primary completion date: 2028-07-01
- has results: false
- data source: ClinicalTrials.gov
- data processed: 2026-10-29T09:00:05
- modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Topics: [CRISPR & Gene-Editing Therapies](https://space-kitty.com/topics/gene-editing-therapies)

Cited in dossiers:
- [CRISPR & Gene-Editing Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/gene-editing-therapies)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.